Modulation of Venlafaxine Hydrochloride Release from Press Coated Matrix Tablet

被引:5
作者
Gohel, M. C. [1 ]
Soni, C. D. [1 ]
Nagori, S. A. [1 ]
Sarvaiya, K. G. [1 ]
机构
[1] LM Coll Pharm, Dept Pharmaceut & Pharmaceut Technol, Ahmadabad 308009, Gujarat, India
关键词
Venlafaxine hydrochloride; modified release; press coating; hydroxypropylmethylcellulose;
D O I
10.4103/0250-474X.42974
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
The aim of present study was to prepare novel modified release press coated tablets of venlafaxine hydrochloride. Hydroxypropylmethylcellulose K4M and hydroxypropylmethylcellulose K100M were used as release modifier in core and coat, respectively. A 32 full factorial design was adopted in the optimization study. The drug to polymer ratio in core and coat were chosen as independent variables. The drug release in the first hour and drug release rate between 1 and 12 h were chosen as dependent variables. The tablets were characterized for dimension analysis, crushing strength, friability and in vitro drug release. A check point batch, containing 1:2.6 and 1:5.4 drug to polymer in core and coat respectively, was prepared. The tablets of check point batch were subjected to in vitro drug release in dissolution media with pH 5, 7.2 and distilled water. The kinetics of drug release was best explained by Korsmeyer and Peppas model (anomalous non-Fickian diffusion). The systematic formulation approach enabled us to develop modified release venlafaxine hydrochloride tablets.
引用
收藏
页码:292 / 297
页数:6
相关论文
共 30 条
[1]
RELEASE MECHANISMS IN GELFORMING SUSTAINED-RELEASE PREPARATIONS [J].
BAMBA, M ;
PUISIEUX, F ;
MARTY, JP ;
CARSTENSEN, JT .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1979, 2 (5-6) :307-315
[2]
Banker G. S., 1986, The theory and practice of industrial pharmacy, P293
[3]
BHATTACHARYA S, 2005, Patent No. 255295
[4]
A reversed-phase HPLC method development for the separation of new antidepressants [J].
Dallet, P ;
Labat, L ;
Richard, M ;
Langlois, MH ;
Dubost, JP .
JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, 2002, 25 (01) :101-111
[5]
DALLET P, 2001, EUR J EMERG MED, V8, P79
[6]
ESTABLISHMENT OF SINK CONDITIONS IN DISSOLUTION RATE DETERMINATIONS - THEORETICAL CONSIDERATIONS AND APPLICATION TO NONDISINTEGRATING DOSAGE FORMS [J].
GIBALDI, M ;
FELDMAN, S .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1967, 56 (10) :1238-&
[7]
Gohel M C, 2002, Boll Chim Farm, V141, P21
[10]
ANALYSIS OF DATA ON MEDICAMENT RELEASE FROM OINTMENTS [J].
HIGUCHI, WI .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1962, 51 (08) :802-&